SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
VSee Health issued 1 million restricted shares and two promissory notes (totaling $50K–$125K) to settle disputes with a creditor regarding covenant breaches on an existing debt instrument, including failure to file registration statements and transfer agent instructions.
View raw filing on EDGAR →Vista Credit Strategic Lending Corp. completed an unregistered sale of 150,533 shares of Class I and 7,841 shares of Class S common stock for $3.03 million pursuant to subscription agreements, relying on Section 4(a)(2) and Regulations D and S exemptions.
View raw filing on EDGAR →The filing discloses an unregistered sale of 9,457,500 Class A shares and 3,690,759 Class E shares for aggregate consideration of approximately $131.5 million, conducted under Section 4(a)(2) and Regulation D Rule 506. This is a classic private placement of equity securities exempt from registration, which is material to investors as it represents significant dilution and capital raising activity.
View raw filing on EDGAR →MannKind entered into a Securities Purchase Agreement on July 23, 2026, to sell 10,440,838 shares of common stock at $3.89 per share and 2,412,632 pre-funded warrants at $3.88 per warrant in a private placement, raising approximately $50 million in gross proceeds. The unregistered sale under Section 4(a)(2) of the Securities Act represents a dilutive equity issuance, with proceeds intended for general corporate purposes including a $45 million contingent value rights payment triggered by FDA approval of Furoscix ReadyFlow.
View raw filing on EDGAR →PennantPark Private Income Fund completed an unregistered sale of 31,142 common shares for approximately $805,000 to accredited investors pursuant to Section 4(a)(2) and Regulation D.
View raw filing on EDGAR →Interactive Strength exercised Class B Incremental Warrants resulting in the issuance of a $2,000,000 convertible note and 305,810 common stock warrants with favorable conversion terms (110% uplift, alternate conversion at 85% of VWAP in default) and low conversion prices ($3.597 and $5.527 per share), representing a material dilutive capital raise through an unregistered private placement under Section 4(a)(2) and Regulation D.
View raw filing on EDGAR →On July 21, 2026, the Company entered into an exchange agreement whereby existing stockholders exchanged 392,766 shares of common stock for pre-funded warrants to purchase the same number of shares at $0.0001 per share, relying on Section 3(a)(9) exemption. The transaction restructures the capital stack and materially increases potential dilution, particularly given the warrants' minimal exercise price and RTW Investments' significant existing stake of approximately 38% post-Exchange.
View raw filing on EDGAR →Apollo Asset Backed Credit Company LLC completed unregistered sales of equity securities totaling approximately $48.3 million across Series I and Series II share classes to third-party investors as of July 1, 2026, exempt from registration under Section 4(a)(2) and Regulations D and S.
View raw filing on EDGAR →The exhibit announces a concurrent registered direct offering of 1,281,646 ADSs (384.5 million ordinary shares) at US$3.16 per ADS for US$4.1 million gross proceeds, plus unregistered warrants and an Australian private placement and share purchase plan totaling up to A$12.7 million. This is a material dilutive equity issuance to accredited institutional investors under Section 4(a)(2) and Regulation D, with warrants exercisable at US$3.79 per ADS expiring July 31, 2029, and options at A$0.018 per option. The offering is subject to shareholder approval at an extraordinary general meeting scheduled for September 11, 2026.
View raw filing on EDGAR →The 6-K discloses a 1-for-11 reverse stock split effective July 31, 2026, which consolidates 6,132,100 shares into approximately 557,464 shares. While a reverse split itself is a capital structure adjustment rather than a new issuance, the filing also references recent dilutive equity issuances (June 2026 PIPE private placement and June 2026 convertible note) and adjustments to warrant exercise prices, signaling capital-raising activity and shareholder dilution. The reverse split is typically undertaken to address low stock price and maintain listing compliance, often following dilutive financings. The materiality lies in the capital structure change and its implications for existing shareholders.
View raw filing on EDGAR →AMR Resources Acquisition Corp consummated its IPO on July 16, 2026, issuing 26,000,000 units (including 1,000,000 from over-allotment exercise) at $10.00 per unit for $260 million in gross proceeds, plus 707,500 private placement units for $7.075 million. This is a material capital raise through equity issuance. While technically a SPAC IPO (blank-check company), the disclosure centers on the issuance of equity securities and capital raised, which fits the dilutive_issuance category. The alternative classification would be operational_other (as a SPAC formation event), but the primary material event disclosed is the equity capital raise itself.
View raw filing on EDGAR →VivoSim Labs closed a private placement on July 17, 2026, issuing pre-funded warrants and common warrants to purchase approximately 4.7 million shares of common stock for gross proceeds of $4.0 million.
View raw filing on EDGAR →The press release announces a registered direct offering of 4.5 million units (each consisting of one Class A ordinary share and one common warrant) at $2.00 per unit, generating approximately $9 million in gross proceeds. This is a classic dilutive equity issuance to institutional investors under a shelf registration statement (Form F-3), materially diluting existing shareholders and raising capital through the sale of registered securities.
View raw filing on EDGAR →The 6-K discloses a private placement (PIPE transaction) in which INLIF Limited issued 40,000 Class B ordinary shares to Kerui Enterprise Limited at $2.58 per share for $103,200 in gross proceeds on July 22, 2026. The shares were issued pursuant to Section 4(a)(2) of the Securities Act and Regulation S, explicitly unregistered. This is a classic dilutive equity issuance that would materially affect a reasonable investor's assessment of ownership dilution and capital structure.
View raw filing on EDGAR →Ondas Inc. completed an unregistered sale of equity securities in a private placement exempt from registration under Regulation D. The issuance is material to investors as it affects ownership dilution and the company's capital structure.
View raw filing on EDGAR →Pacific Booker announces the closing of a non-brokered private placement raising $4,000,001.90 through issuance of 1,860,466 units (each comprising one common share and one warrant). This is a material unregistered equity issuance typical of small-cap mining companies raising capital; the proceeds are substantial relative to the company's likely market cap, and the dilution to existing shareholders is significant. A director participated in the placement, further confirming its materiality.
View raw filing on EDGAR →ARMOUR entered into Amendment No. 8 to its Equity Sales Agreement on July 24, 2026, increasing the number of shares available for issuance under an at-the-market offering program by 25,000,000 shares, bringing the total to 25,544,352 shares available for sale through multiple sales agents.
View raw filing on EDGAR →The filing discloses an unregistered sale of 416,954.313 shares of common stock at $9.85 per share for an aggregate offering price of $4,107,000, conducted pursuant to subscription agreements and exempt under Section 4(a)(2) and Regulation D. This is a classic private placement that dilutes existing shareholders and raises material capital for the company.
View raw filing on EDGAR →LGL Group completed a transferable subscription rights offering that resulted in the issuance of 6,062,714 shares of common stock, raising approximately $41.8 million in gross proceeds. This represents a 92.6% subscription rate and increases outstanding shares from approximately 6.5 million to 12.6 million—a material dilution to existing shareholders. The filing discloses the completion of this equity issuance with specific share counts and pro forma balance sheet impacts, which is characteristic of a dilutive equity issuance event.
View raw filing on EDGAR →The filing discloses multiple unregistered equity issuances totaling approximately $789,017 in balance-sheet improvement, including a debt-to-equity conversion of $53,150 (Item 3.02), warrant exercises generating $310,822.90 in proceeds, and conversion of deferred compensation obligations into 20,754 shares. These transactions represent dilutive equity issuances relying on Section 4(a)(2) exemptions, characteristic of private placements and capital raises at small-cap issuers.
View raw filing on EDGAR →Digital Brands Group entered into a Securities Purchase Agreement on July 23, 2026, to issue a $3.529 million convertible promissory note and an Equity Line of Credit (ELOC) facility for up to $100 million in common stock sales. The convertible note is convertible into common stock at 90% of the lowest closing price during a five-day period, and the ELOC grants the purchaser the right to purchase up to $100 million of common stock at 95% of the lowest daily VWAP, both subject to a 19.99% beneficial ownership cap. This represents a significant dilutive equity issuance with substantial downside pricing mechanisms and a multi-year commitment period, materially affecting shareholder equity and voting power.
View raw filing on EDGAR →The 6-K discloses the closing of the first tranche of a private placement involving issuance of unsecured promissory notes (US$10M principal), common warrants to purchase 29.1M ordinary shares, pre-funded warrants to purchase 1.1M ordinary shares, and 676,205 ordinary shares, with US$2M funded at closing. This is a classic dilutive equity issuance with warrant coverage that would materially affect existing shareholders' ownership and voting power, and the concurrent equity purchase agreement permits up to US$100M in additional ordinary shares or pre-funded warrants.
View raw filing on EDGAR →The filing discloses a settlement agreement under which Algorhythm will issue up to 5,000,000 shares of common stock to Continuation Capital, Inc. to settle $1,928,014 in liabilities. This is an unregistered private placement exempt under Section 3(a)(10) of the Securities Act, representing a dilutive equity issuance to settle debt. While Item 5.02 also addresses executive compensation amendments, the principal material event is the equity issuance to resolve outstanding liabilities.
View raw filing on EDGAR →INVO Fertility entered into an Any Market Purchase Agreement with Alumni Capital LP granting the investor the right to purchase up to $15 million (potentially $50 million) of common stock at the Company's discretion. The agreement represents a dilutive equity line of credit arrangement, with shareholder approval obtained for inducement warrants (up to 1,893,492 shares) and future equity financing at below-market prices (up to 20% dilution), supported by an increase in authorized shares from 50 million to 250 million.
View raw filing on EDGAR →Essential Properties Realty Trust entered into an ATM (at-the-market) equity offering sales agreement on July 24, 2026, providing for the offer and sale of up to $750.0 million in common stock through multiple agents. The filing explicitly describes the mechanics of an at-the-market offering under Rule 415 of the Securities Act, including forward sale agreements with financial institutions. This is a material dilutive issuance of equity securities that would affect a reasonable investor's assessment of share dilution and the company's capital structure.
View raw filing on EDGAR →Stark Focus Group entered into a material definitive agreement for an unregistered private placement of 8.4 million shares (4.2 million to each of two investors) for $400,000 total ($200,000 per investor), representing 45.78% aggregate dilution to existing shareholders under Section 4(a)(2) of the Securities Act.
View raw filing on EDGAR →A reverse stock split (1-for-5) is a capital structure change that affects all shareholders' holdings proportionally. While reverse splits are often associated with financial distress or delisting risk mitigation, this disclosure focuses on the mechanical amendment to the Articles of Incorporation and the automatic combination of shares. The event is material to investors as it affects share count and potentially signals underlying financial or listing concerns, but the taxonomy lacks a precise fit—it is neither a dilutive issuance (which involves new equity creation) nor a governance amendment (which would be routine). This is best classified as a capital structure event with material implications, though the confidence is low due to the mismatch between the event's nature and available categories.
View raw filing on EDGAR →The filing discloses an unregistered sale of equity securities totaling approximately $239 million across three share classes (Class I-Series 1, Class S, and Class D shares) on July 1, 2026, exempt under Section 4(a)(2) and Regulations D and S. This is a classic dilutive private placement. The materiality is underscored by the substantial aggregate consideration and the disclosure that the company has raised approximately $7.5 billion cumulatively since inception through such continuous private offerings.
View raw filing on EDGAR →The filing discloses an unregistered sale of equity securities totaling approximately $268.6 million across multiple share classes (Class I-Series 1, Class U, Class D, and Class S Shares) to investors under Section 4(a)(2) and Regulations D and S. This is a classic dilutive issuance of unregistered equity. The materiality is evident from the substantial aggregate consideration and the disclosure that the company has sold approximately $10.4 billion in shares since inception as part of its continuous private offering.
View raw filing on EDGAR →The filing discloses an unregistered sale of 764,818 common shares for $20,000,000 pursuant to Section 4(a)(2) and Regulation D/S under the Securities Act. This is a classic dilutive equity issuance by a closed-end fund raising capital through a private placement, which materially affects existing shareholders' ownership percentages and is a significant capital event for the registrant.
View raw filing on EDGAR →TPG Private Equity Opportunities, L.P. sold $84.4 million of unregistered limited partnership units on July 1, 2026, as part of a continuous private offering exempt under Section 4(a)(2) and Regulation D, including through a feeder vehicle for tax-exempt and non-U.S. investors.
View raw filing on EDGAR →Golub Capital Private Income Fund S issued 69,843 common shares of beneficial interest for $1,686,000 in consideration pursuant to Section 4(a)(2), Regulation D, and/or Regulation S exemptions.
View raw filing on EDGAR →The Fund sold 51,511 unregistered common shares of beneficial interest for $1,244,500 as of July 1, 2026, pursuant to subscription agreements and exempt from Securities Act registration under Section 4(a)(2), Regulation D, and/or Regulation S.
View raw filing on EDGAR →The filing discloses issuance of $350 million (plus $30 million option) of Exchangeable Senior First-Lien Secured PIK Notes due 2030, which are convertible debt instruments that trigger anti-dilution adjustments to existing public warrants. The warrant exercise price decreased from $13.61 to $12.81 and warrant holders receive more shares (1.0140 to 1.0772 shares per warrant), indicating material dilution to existing shareholders. This is a significant capital-raising event with direct dilutive consequences to equity holders.
View raw filing on EDGAR →HYEX entered into a Securities Purchase Agreement with LABRYS FUND II, L.P. to issue a convertible promissory note with $258,750 principal (net proceeds $225,000) convertible into common stock at the lesser of $2.00 per share or 75% of the lowest closing bid price during the preceding 15 trading days, together with an unregistered sale of equity securities under Section 4(a)(2) of the Securities Act to an accredited investor. This private placement creates significant dilution potential for existing shareholders.
View raw filing on EDGAR →ClearSign Technologies completed a private placement of 500,000 shares of restricted common stock to Otter Capital LLC at $3.54 per share for gross proceeds of $1.77 million. The unregistered securities were issued under Section 4(a)(2) and Regulation D exemptions, requiring a waiver of underwriter lock-up restrictions and representing a material capital raise and equity dilution event.
View raw filing on EDGAR →Magnolia Oil & Gas issued 46.3 million shares of Class A common stock at $23.75 per share, with underwriters exercising a 30-day option for an additional 6.9 million shares, closing on July 22, 2026. This is a registered equity offering (Form S-3) that materially dilutes existing shareholders and raises capital for the company's pending acquisition of WildFire Intermediate Holdings, LLC. The scale and purpose of the offering make it material to investors.
View raw filing on EDGAR →QXO filed a prospectus supplement on July 23, 2026 to register the resale of 41.4 million shares of common stock issuable upon conversion of Series C Convertible Preferred Stock, plus 96,267 shares of Preferred Stock itself, pursuant to an Investment Agreement dated January 5, 2026. This represents a substantial dilutive issuance of convertible securities to investors, materially affecting share count and ownership structure.
View raw filing on EDGAR →In connection with the business combination, PIPE investors purchased 24 million shares of New Freenome Common Stock at $10.00 per share for aggregate proceeds of $240 million pursuant to subscription agreements, constituting a material unregistered private placement under Section 4(a)(2) of the Securities Act.
View raw filing on EDGAR →Blackstone Private Equity Strategies Fund L.P. sold approximately $740 million in unregistered limited partnership units across two funds on July 1, 2026, pursuant to Section 4(a)(2) and Regulation D exemptions to accredited investors and qualified purchasers.
View raw filing on EDGAR →Blackstone Infrastructure Strategies L.P. and its feeder fund sold approximately $357.6 million in unregistered limited partnership units to accredited investors and qualified purchasers on July 1, 2026, pursuant to Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →Apollo Debt Solutions BDC sold 186,709 unregistered Class I Common Shares for $4,449,521 to feeder vehicles, relying on Section 4(a)(2) and Regulation S exemptions from Securities Act registration. This capital raise represents a significant equity dilution event for existing shareholders.
View raw filing on EDGAR →Summit Therapeutics entered into an at-the-market (ATM) distribution agreement with J.P. Morgan Securities to offer and sell up to $380 million in common stock shares. This is a dilutive equity issuance structured as an ATM offering under Rule 415(a)(4), which allows the company to raise capital by selling shares at prevailing market prices. The magnitude ($380M) and structure (unregistered equity sales through a sales agent) are material to investors assessing capital structure and shareholder dilution.
View raw filing on EDGAR →The filing discloses a full cashless exercise of 428,862,444 warrants resulting in the issuance of 360,534,431 Class A ordinary shares. This represents a significant dilutive equity issuance—the newly issued shares are restricted but will eventually enter the float, materially affecting share count and ownership percentages. While technically a warrant exercise rather than a primary offering, the economic substance is a dilutive equity issuance that would affect a reasonable investor's assessment of ownership and capital structure.
View raw filing on EDGAR →Zoomcar announced an extension of its warrant-for-common-stock exchange offer, which involves converting outstanding warrants into shares of common stock. This is a dilutive capital transaction that increases the share count and requires stockholder approval to increase authorized shares. While the core event is a warrant exchange rather than a new issuance, the economic effect—dilution of existing shareholders through warrant conversion—aligns most closely with dilutive_issuance. The extension itself is administrative, but the underlying offer materially affects capital structure.
View raw filing on EDGAR →The 6-K furnishes a legal opinion validating the remaining $53.9 million of ordinary shares issuable under a Controlled Equity Offering Sales Agreement (ATM offering) with Cantor Fitzgerald and Mizuho Securities. This is a material unregistered equity issuance mechanism that dilutes existing shareholders and signals the company is raising capital through an at-the-market offering, a hallmark disclosure under Item 3.02 equivalent for foreign private issuers.
View raw filing on EDGAR →Change Agents Corporation entered into an Equity Purchase Agreement with Hudson Global Ventures on July 22, 2026, establishing a $10 million equity line of credit whereby the Company may issue shares of common stock at $0.30 per share, plus warrants to purchase 925,925 shares at $0.01 per share. The warrant and shares are offered and sold in reliance on Section 4(a)(2) and Rule 506(b) exemptions under the Securities Act.
View raw filing on EDGAR →FatPipe disclosed a recently filed Form S-3 registration statement and an at-the-market (ATM) offering program. The CEO's letter explicitly states the company has "not issued nor sold any shares" under the ATM to date, but the registration statement provides the legal framework for future dilutive equity issuances. The disclosure of an ATM program is material to investors as it signals potential future dilution and capital-raising activity, even though no shares have yet been issued. This is a forward-looking disclosure of dilutive issuance capability.
View raw filing on EDGAR →Eva Live Inc entered into a securities purchase agreement to issue a $2.16 million secured convertible note with an 8% original issue discount, convertible into common stock at 87% of the 10-day VWAP (floor price $0.472). The filing explicitly discloses this under Item 3.02 (Unregistered Sales of Equity Securities) and Item 1.01 (Material Definitive Agreement), with conversion shares registered on the company's Form S-3. This is a dilutive equity issuance raising capital through convertible debt, a material financing event for a small-cap company.
View raw filing on EDGAR →Five Star Bancorp entered into an underwriting agreement on July 22, 2026 to issue and sell 2,725,000 shares of common stock at $44.00 per share in a registered public offering, with expected net proceeds of approximately $112.9–$113.6 million. Underwriters received a 30-day option to purchase an additional 408,750 shares, further increasing dilution potential.
View raw filing on EDGAR →